Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-06

Clinical Trial Update: DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor [NA]

View source ↗

Summary

The DIVIT study, a trial evaluating diet and vitamin supplementation in patients with neuroendocrine tumors, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: Neuroendocrine Tumor | NA | Status: COMPLETED